Literature DB >> 25243619

Nail dystrophy, edema, and eosinophilia: harbingers of severe chronic GVHD of the skin in children.

J T Huang1, C N Duncan2, D Boyer3, H Khosravi4, L E Lehmann2, A Saavedra5.   

Abstract

The prognostic value of adnexal findings in chronic GVHD (cGVHD) has not been investigated in children. Dermatologic examinations were performed in a severe cohort of 11 children with skin cGVHD seen over a 2-year period. Findings were compared with 25 additional patients with skin cGVHD and 97 control patients. In 36 patients with skin cGVHD, nail dystrophy was present in 45% of patients, and was significantly associated with sclerotic disease and lung cGVHD. Pterygium inversum unguis (PIU) was associated with severe lung disease, with significantly lower % predicted FVC and FEV1 in those with PIU than those without. Forty-four percent of GVHD patients had preceding peripheral edema and 56% had preceding peripheral eosinophilia. Peripheral edema and eosinophilia were significantly associated with sclerotic cGVHD and persisted until the diagnosis of cGVHD in all patients. Comparison of data with control patients showed that incidence of nail dystrophy, incidence of peripheral edema and mean peak peripheral eosinophil count of patients with skin cGVHD was significantly higher than those without cGVHD. This study suggests that nail dystrophy, persistent peripheral edema and persistent peripheral eosinophilia are harbingers of severe cGVHD of the skin in children. The presence of PIU may be a harbinger of severe lung involvement.

Entities:  

Mesh:

Year:  2014        PMID: 25243619     DOI: 10.1038/bmt.2014.194

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


  20 in total

1.  Localized edema with sclerodermatous evolution: a possible form of skin chronic graft-versus-host disease associated with endothelial activation.

Authors:  Mathilde Tardieu; Michel Rybojad; Régis Peffault de Latour; Marie Robin; Adèle de Masson; Aliénor Xhaard; Hélène Le Buanec; Nathalie Parquet; Flore Sicre de Fontbrune; Anne Bergeron; Catherine Scieux; Valérie Dessirier; Armand Bensussan; Martine Bagot; Gérard Socié; Jean-David Bouaziz
Journal:  Blood       Date:  2013-07-18       Impact factor: 22.113

2.  Fasciitis after allogeneic peripheral blood stem cell transplantation in a patient with chronic myelogenous leukemia.

Authors:  Kee Won Kim; Chong Hyeon Yoon; Chul Seung Kay; Hee Jung Kim; Eun Hee Lee; Suk Young Park
Journal:  J Clin Rheumatol       Date:  2003-02       Impact factor: 3.517

3.  Health-related quality of life of pediatric patients receiving allogeneic stem cell or bone marrow transplantation: results of a longitudinal, multi-center study.

Authors:  R Felder-Puig; A di Gallo; M Waldenmair; P Norden; A Winter; H Gadner; R Topf
Journal:  Bone Marrow Transplant       Date:  2006-07       Impact factor: 5.483

4.  Incidence and prognostic value of eosinophilia in chronic graft-versus-host disease after nonmyeloablative hematopoietic cell transplantation.

Authors:  Imran Ahmad; Annie-Claude Labbé; Miguel Chagnon; Lambert Busque; Sandra Cohen; Thomas Kiss; Silvy Lachance; Denis-Claude Roy; Guy Sauvageau; Jean Roy
Journal:  Biol Blood Marrow Transplant       Date:  2011-05-03       Impact factor: 5.742

5.  Lichen sclerosus and eosinophilic fasciitis as manifestations of chronic graft-versus-host disease: expanding the sclerodermoid spectrum.

Authors:  Julie V Schaffer; Jennifer M McNiff; Stuart Seropian; Dennis L Cooper; Jean L Bolognia
Journal:  J Am Acad Dermatol       Date:  2005-10       Impact factor: 11.527

6.  Graft-versus-host disease after nonmyeloablative versus conventional hematopoietic stem cell transplantation.

Authors:  Marco Mielcarek; Paul J Martin; Wendy Leisenring; Mary E D Flowers; David G Maloney; Brenda M Sandmaier; Michael B Maris; Rainer Storb
Journal:  Blood       Date:  2003-03-27       Impact factor: 22.113

Review 7.  Chronic graft-versus-host disease (GVHD) in children.

Authors:  Kristin Baird; Kenneth Cooke; Kirk R Schultz
Journal:  Pediatr Clin North Am       Date:  2010-02       Impact factor: 3.278

8.  Eosinophilia correlates with the presence or development of chronic graft-versus-host disease in children.

Authors:  David A Jacobsohn; Tali Schechter; Roopa Seshadri; Kimberly Thormann; Reggie Duerst; Morris Kletzel
Journal:  Transplantation       Date:  2004-04-15       Impact factor: 4.939

9.  Severity of chronic graft-versus-host disease: association with treatment-related mortality and relapse.

Authors:  Stephanie J Lee; John P Klein; A John Barrett; Olle Ringden; Joseph H Antin; Jean-Yves Cahn; Matthew H Carabasi; Robert Peter Gale; Sergio Giralt; Gregory A Hale; Osman Ilhan; Philip L McCarthy; Gerard Socie; Leo F Verdonck; Daniel J Weisdorf; Mary M Horowitz
Journal:  Blood       Date:  2002-07-15       Impact factor: 22.113

10.  Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients.

Authors:  H M Shulman; K M Sullivan; P L Weiden; G B McDonald; G E Striker; G E Sale; R Hackman; M S Tsoi; R Storb; E D Thomas
Journal:  Am J Med       Date:  1980-08       Impact factor: 4.965

View more
  4 in total

Review 1.  How I treat refractory chronic graft-versus-host disease.

Authors:  Stefanie Sarantopoulos; Adela R Cardones; Keith M Sullivan
Journal:  Blood       Date:  2019-01-23       Impact factor: 22.113

2.  Inhibition of the IRE-1α/XBP-1 pathway prevents chronic GVHD and preserves the GVL effect in mice.

Authors:  Steven D Schutt; Yongxia Wu; Chih-Hang Anthony Tang; David Bastian; Hung Nguyen; M Hanief Sofi; MengMeng Zhang; Chen Liu; Kris Helke; Carole Wilson; Lynn M Schnapp; Juan R Del Valle; Chih-Chi Andrew Hu; Xue-Zhong Yu
Journal:  Blood Adv       Date:  2018-02-27

Review 3.  Methods to Assess Disease Activity and Severity in Cutaneous Chronic Graft-versus-Host Disease: A Critical Literature Review.

Authors:  Hadir Shakshouk; Eric R Tkaczyk; Edward W Cowen; Rokea A El-Azhary; Shahrukh K Hashmi; Saad J Kenderian; Julia S Lehman
Journal:  Transplant Cell Ther       Date:  2021-06-06

4.  National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IIa. The 2020 Clinical Implementation and Early Diagnosis Working Group Report.

Authors:  Carrie L Kitko; Joseph Pidala; Hélène M Schoemans; Anita Lawitschka; Mary E Flowers; Edward W Cowen; Eric Tkaczyk; Nosha Farhadfar; Sandeep Jain; Philipp Steven; Zhonghui K Luo; Yoko Ogawa; Michael Stern; Greg A Yanik; Geoffrey D E Cuvelier; Guang-Shing Cheng; Shernan G Holtan; Kirk R Schultz; Paul J Martin; Stephanie J Lee; Steven Z Pavletic; Daniel Wolff; Sophie Paczesny; Bruce R Blazar; Stephanie Sarantopoulos; Gerard Socie; Hildegard Greinix; Corey Cutler
Journal:  Transplant Cell Ther       Date:  2021-04-09
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.